Clinical Trial Update: Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease

View source ↗

Summary

A completed clinical trial studying the timing of low-molecular-weight heparin therapy in cancer patients with venous thromboembolism and related thromboembolic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparin (LMWH) (low molecular weight heparin)

Snippet

Sponsor: Delos Clinical | Conditions: Venous Thromboembolism, Pulmonary Thromboembolisms | Status: COMPLETED